Filing Details
- Accession Number:
- 0001562180-20-006684
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-11-12 20:01:26
- Reporting Period:
- 2020-11-09
- Accepted Time:
- 2020-11-12 20:01:26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 897448 | Amarin Corp Plc | AMRN | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1199637 | F John Thero | C/O Amarin Pharma, Inc. 440 Us Highway 22 Bridgewater NJ 08807 | President And Ceo | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2020-11-09 | 134,739 | $3.40 | 2,691,144 | No | 4 | M | Direct | |
| Ordinary Shares | Acquisiton | 2020-11-10 | 615,261 | $3.40 | 3,306,405 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2020-11-10 | 153,840 | $4.13 | 3,152,565 | No | 4 | S | Direct | |
| Ordinary Shares | Disposition | 2020-11-11 | 413,565 | $4.07 | 2,739,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Stock Option (Right to Buy) | Disposition | 2020-11-09 | 134,739 | $0.00 | 134,739 | $3.40 |
| Ordinary Shares | Stock Option (Right to Buy) | Disposition | 2020-11-10 | 615,261 | $0.00 | 615,261 | $3.40 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 615,261 | 2020-11-10 | No | 4 | M | Direct | |
| 0 | 2020-11-10 | No | 4 | M | Direct |
Footnotes
- Acquisitions reported in this Form 4 pertain to exercises of stock options scheduled to expire on Nov. 10, 2020. In the first of the reported acquisitions, dated Nov. 9, 2020, 134,739 shares were acquired for $500,000, in cash, covering the exercise price of the stock options and the related taxes. The second acquisition, dated Nov. 10, 2020, involved shares acquired by the Reporting Person for cash offset by proceeds from sales of a portion of the acquired shares with the net remaining shares, after paying for cost for this second acquisition including taxes, added to the holdings of the Reporting Person. The result of these transactions, for cash and other consideration paid, was a net increase in shares held by the Reporting Person of 182,595 shares.
- The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.11 to $4.16, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.01 to $4.14, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- Please see the section titled "Remarks" below for additional information.
- The stock option granted to the Reporting Person is fully vested as of the date hereof.
Billionaire Hedge Funds
